Best Lutetium-177 therapy Doctors Abroad for Australian Patients

Dr. Kezban Berberoglu is a professor of nuclear medicine at Anadolu Medical Center in Istanbul. She completed training at the Johns Hopkins University School of Medicine in Baltimore. Dr. Berberoglu specializes in nuclear oncology and nuclear cardiology. She treats thyroid and prostate cancers using radioisotope therapies. She is a member of the European Association of Nuclear Medicine.

• Performs Lutetium-177 and Actinium-225 therapies for oncology patients.
• Expert in PET-CT imaging using Gallium 68 for oncology cases.
• Member of the Turkish Nuclear Medicine Association cardiology work group.
• Works at an MTQUA Top 10 world hospital affiliated with Johns Hopkins.

Associate Professor Mustafa Solak gained international experience at the University of Texas MD Anderson Cancer Center – arguably the world's most prestigious cancer hospital.

• Completed an oncology fellowship at the Hacettepe University Cancer Institute
• Specialises in systemic treatments for advanced gastrointestinal and prostate malignancies
• Expertise includes modern immunotherapy and targeted interventions for complex cases
• Active member of the Turkish Society of Medical Oncology
• Oversees modern cancer care at Hisar Hospital Intercontinental

Associate Professor Nail Paksoy is a highly published medical oncologist who specialises in advanced cancer therapies and clinical research at Medipol Bahçelievler University Hospital.

• ESMO Board Certified in Medical Oncology, an international mark of excellence in cancer care
• Investigated Lutetium-177 DOTATATE outcomes in multicentre real-world studies
• Contributed to major clinical trials for Roche, Pfizer, and AstraZeneca
• Authored over 40 international peer-reviewed articles on tumour response and survival
• Holds academic leadership as an Associate Professor of Medical Oncology

Professor Mustafa Serkan Alemdar is a dual-certified specialist in internal medicine and medical oncology at Medical Park Antalya Hospital Complex.

• Completed specialist oncology training at Akdeniz University Faculty of Medicine
• Managed complex cancer cases at Akdeniz University Hospital for over a decade
• Served as a specialist at the Antalya Training and Research Hospital
• Expertise covers both inpatient and outpatient systemic cancer treatments
• Member of the Turkish Society of Medical Oncology

Professor Emel Ceylan Gunay is a leading specialist in radionuclide treatments at Liv Hospital Ulus, focusing on complex molecular scanning and nuclear oncology.

• Holds a Professor title and leads nuclear medicine programmes at one of Turkey's premier private hospitals
• Published 35 international articles on molecular imaging and advanced radionuclide therapies
• Expert in targeted radioactive treatments for neuroendocrine tumours and prostate cancer
• Active member of the Turkey Nuclear Medicine Association and several international scientific boards

Dr Shruti Kate leads the medical oncology department at HCG Manavata Cancer Centre and previously served at the prestigious Tata Memorial Hospital. She specializes in managing complex solid tumours and aggressive cancers using immunotherapy and systemic treatments.

• Recognised internationally as the solo Indian travel award recipient at the 2018 World Conference on Lung Cancer
• Trained at Maulana Azad Medical College and Tata Memorial Hospital
• Expertise in both solid tumours and haematological malignancies
• Active member of the American Society of Clinical Oncology and ESMO

Dr Chaitainya Borde leads the nuclear medicine services at HCG Manavata Cancer Centre. He has personally managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients.

• Specialises in Lutetium-177 and radioiodine therapies for advanced cancer cases
• Expertise includes complex PET-CT scans for precise tumour mapping
• Provides comprehensive nuclear cardiology services alongside oncological work
• Published researcher contributing to oncology and nuclear medicine journals
• Works at an oncology centre recognised for high-volume radionuclide therapies

Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.

• Expert in functional rehabilitation for patients recovering from oral cancer.
• Active researcher with multiple publications in various medical journals.
• Works at an NABH-accredited center that treats over 75,000 patients yearly.
• Treats complex conditions including tongue, thyroid, and tonsil cancers.

Dr. Lalit Banswal is a surgical oncologist at HCG Manavata Cancer Centre in Nashik. He has successfully performed more than 10,000 major surgeries. Dr. Banswal focuses on gastrointestinal cancer and robotic surgical techniques. He completed a two-year fellowship at the Tata Medical Centre, Kolkata.

• Specializes in minimally invasive procedures, including laparoscopy and thoracoscopy.
• Performs robotic cancer surgeries and advanced endoscopic procedures.
• Served as a former assistant professor at the State Cancer Institute.
• Acts as a co-principal investigator for original clinical research projects.
• Treats complex esophageal, stomach, colon, and rectal cancers.

Dr. Raj Nagarkar has performed over 50,000 cancer surgeries at HCG Manavata Cancer Centre. He specializes in breast and thoracic surgical oncology. Dr. Nagarkar trained at the prestigious Tata Memorial Hospital in Mumbai. He is a Member of the Royal College of Surgeons in Edinburgh.

• Participated as a lead investigator in more than 200 clinical trials.
• Serves as a professor for DNB Superspecialty Surgical Oncology.
• Expert in complex procedures including mastectomy and thoracic resections.
• Founder of Curie Manavata Cancer Centre, a major regional treatment hub.